← Browse by Condition
Medical Condition
advanced fallopian tube carcinoma
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2
ClinicalMetric aggregates all active clinical trials for advanced fallopian tube carcinoma from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries. Trials are updated daily as new studies open, status changes, and enrollment targets are updated.
- Recruiting trials — currently enrolling participants, with eligibility criteria
- Phase 1–4 studies — from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary for every trial listing
NCT06639074 Phase 2
Recruiting
Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial
Enrollment
78 pts
Location
United States
Sponsor
Mayo Clinic
NCT05969860 Phase 2
Recruiting
At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
Enrollment
220 pts
Location
United States
Sponsor
Mayo Clinic